Event Details
Dates: August 24 to 26, 2026
Location: Capital Hilton, 1001 16th St NW, Washington, DC 20036
Event Website: https://www.nextgenerationdx.com
Event Overview
Cizzle Bio will attend the Next Generation DX Summit 2026, a premier conference dedicated to advancing the future of molecular diagnostics, precision medicine, and early disease detection.
The summit brings together clinical laboratory leaders, researchers, physicians, diagnostics developers, biotechnology companies, and healthcare innovators to explore the latest advances in biomarker discovery, genomic technologies, liquid biopsy, molecular testing, and precision diagnostics. Through scientific presentations, panel discussions, and networking opportunities, attendees will gain insight into the technologies and collaborations shaping the future of diagnostic medicine.
Featured Presentation
Cizzle Bio is proud to highlight a featured presentation by Dr. Lary Robinson of Moffitt Cancer Center:
Potential of the CIZ1B Biomarker to Redefine Early Lung Cancer Detection
Date: Monday, August 24, 2026
Time: 11:15 AM EDT
This presentation, part of the Early Cancer Surveillance track, will explore the clinical potential of the CIZ1B biomarker and its role in advancing earlier lung cancer detection. The session will discuss how innovative biomarker technologies may help improve diagnostic pathways and support more informed clinical decision making, reinforcing the growing importance of precision diagnostics in oncology.
From Scientific Dialogue to Clinical Availability
The CIZ1B biomarker at the center of Dr. Robinson's presentation is the same biomarker behind the CIZ1B Biomarker Blood Test for Lung Cancer, now commercially available to licensed healthcare providers in the Dallas-Fort Worth and San Antonio metropolitan areas.
What was once a research conversation is now a clinical option. Licensed providers can review ordering setup steps and begin provider onboarding through the Cizzle Bio website.
Why Attend
Gain insight into the latest advances in molecular diagnostics, biomarker research, and precision medicine.
Explore emerging technologies driving innovation in early cancer detection and clinical diagnostics.
Connect with leaders from academia, healthcare, biotechnology, diagnostics, and the life sciences industry.
Learn from experts shaping the future of next generation diagnostic technologies and personalized medicine.
Cizzle Bio's Focus
As a company advancing biomarker blood tests for early cancer detection, Cizzle Bio values opportunities to collaborate with the scientific and clinical communities driving innovation in diagnostic medicine.
The Next Generation DX Summit 2026 provides an important forum to engage with leaders across molecular diagnostics and precision medicine while highlighting the growing clinical interest in the CIZ1B biomarker. Dr. Lary Robinson's presentation on the CIZ1B biomarker reflects the ongoing scientific dialogue surrounding innovative approaches to earlier lung cancer detection and supports Cizzle Bio's commitment to advancing diagnostic innovation that may improve patient outcomes.
Connect With Cizzle Bio
Cizzle Bio will be attending the summit August 24–26. To connect with the team during the event, contact info@cizzlebio.com.
Not attending? Licensed healthcare providers can learn how to get set up to order the CIZ1B test in our provider guide: How Can Healthcare Providers Order the CIZ1B Lung Cancer Blood Test?